FTC report slams pharmacy 'middlemen' for seemingly driving up prices, limiting access
Pharmacy benefit managers (PBMs) have a significant influence on the availability and affordability of prescription drugs. Scathing new report “These powerful middlemen may be profiting from inflating drug prices and squeezing Main Street pharmacies,” a Federal Trade Commission report concluded. The report signals significantly increased scrutiny of the business practices of PBMs, the opaque intermediaries […]